共 50 条
- [41] Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD) PATHOLOGIE BIOLOGIE, 2015, 63 (01): : 17 - 20
- [42] Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2020, 10 (03): : 95 - 103
- [44] Multiple myeloma-associated amyloidosis and giant cell arteritis ARTHRITIS AND RHEUMATISM, 1998, 41 (07): : 1312 - 1317
- [46] Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E320 - E321
- [47] Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA Annals of Hematology, 2023, 102 : 863 - 876
- [48] Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients Leukemia, 2014, 28 : 2311 - 2316